279 related articles for article (PubMed ID: 26041667)
21. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
[TBL] [Abstract][Full Text] [Related]
22. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
Ogunjimi B; Theeten H; Hens N; Beutels P
J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood Transplantation.
Fukushi K; Konuma T; Monna-Oiwa M; Isobe M; Kato S; Kuroda S; Takahashi S; Nannya Y
Transplant Cell Ther; 2022 Jun; 28(6):339.e1-339.e7. PubMed ID: 35364334
[TBL] [Abstract][Full Text] [Related]
24. Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib.
Pour L; Adam Z; Buresova L; Krejci M; Krivanova A; Sandecka V; Zahradova L; Buchler T; Vorlicek J; Hajek R
Clin Lymphoma Myeloma; 2009 Apr; 9(2):151-3. PubMed ID: 19406726
[TBL] [Abstract][Full Text] [Related]
25. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
26. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
[TBL] [Abstract][Full Text] [Related]
27. Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients.
Swaika A; Paulus A; Miller KC; Sher T; Almyroudis NG; Ball D; Wood M; Masood A; Lee K; Chanan-Khan AA
J Support Oncol; 2012; 10(4):155-9. PubMed ID: 22222250
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
Uy GL; Goyal SD; Fisher NM; Oza AY; Tomasson MH; Stockerl-Goldstein K; DiPersio JF; Vij R
Bone Marrow Transplant; 2009 May; 43(10):793-800. PubMed ID: 19029964
[TBL] [Abstract][Full Text] [Related]
29. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation.
Offidani M; Corvatta L; Olivieri A; Mele A; Brunori M; Montanari M; Rupoli S; Scalari P; Leoni P
Clin Infect Dis; 2001 May; 32(10):1414-22. PubMed ID: 11317241
[TBL] [Abstract][Full Text] [Related]
30. Disseminated zoster in an adult patient with extensive burns: a case report.
Kubota Y; Kosaka K; Hokazono T; Yamaji Y; Tezuka T; Akita S; Kuriyama M; Mitsukawa N
Virol J; 2019 May; 16(1):68. PubMed ID: 31122255
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy.
Furuta Y; Ohtani F; Kawabata H; Fukuda S; Bergström T
Clin Infect Dis; 2000 Mar; 30(3):529-33. PubMed ID: 10722439
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
[TBL] [Abstract][Full Text] [Related]
36. Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?
Lee CJ; Savani BN; Ljungman P
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1783-1787. PubMed ID: 29653205
[TBL] [Abstract][Full Text] [Related]
37. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study.
Becerra JC; Sieber R; Martinetti G; Costa ST; Meylan P; Bernasconi E
Int J Infect Dis; 2013 Jul; 17(7):e529-34. PubMed ID: 23566589
[TBL] [Abstract][Full Text] [Related]
38. Visceral varicella zoster virus infection after stem cell transplantation: a possible cause of severe abdominal pain.
Leena M; Ville V; Veli-Jukka A
Scand J Gastroenterol; 2006 Feb; 41(2):242-4. PubMed ID: 16484131
[TBL] [Abstract][Full Text] [Related]
39. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
[TBL] [Abstract][Full Text] [Related]
40. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
Han CS; Miller W; Haake R; Weisdorf D
Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
